(Q35207602)

7 August 2017

1 reference

title

Divalproex sodium extended-release for the prophylaxis of migraine headache (English)

1 reference

7 August 2017

1 reference

1 reference

Fred G Freitag

1

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Expert Opinion on Pharmacotherapy

7 August 2017

published in

1 reference

7 August 2017

volume

4

1 reference

7 August 2017

issue

9

1 reference

7 August 2017

page(s)

1573-1578

1 reference

Visual cortex excitability in migraine before and after valproate prophylaxis: a pilot study using TMS.

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.9.1573

Possible mechanisms of valproate in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.9.1573

Sodium valproate in the treatment of cluster headache: an open clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.9.1573

A negative trial of sodium valproate in cluster headache: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.9.1573

Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.9.1573

Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.9.1573

Divalproex sodium in migraine prophylaxis: a dose-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.9.1573

10.1517/14656566.4.9.1573

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference